Spatial Genomics & Transcriptomics Market 2023 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2030

Spatial Genomics & Transcriptomics Market Size

Introduction:

Spatial genomics is an interdisciplinary field of biology focusing on the structure, function, evolution, mapping, and editing of genomes and transcriptomics is a method for assigning cell types (identified by the mRNA readouts) to their locations in the histological sections. This method can be used to determine subcellular localization of mRNA molecules and their cellular heterogeneity in tissues, and tumors. The studies of all genes and their associated mRNAs are correspondingly called spatial genomics and transcriptomics. Additionally, spatial genomics and transcriptomics also provides information regarding immune cells as well as determine subcellular distribution of transcripts in various conditions. Spatial genomics has a lot of potential in disease control, as it provides quantitative gene expression data as well as DNA and RNA visualization mapping into tissue components. The global spatial genomics & transcriptomics market is anticipated to experience a substantial growth due to rise in prevalence of genetic disorders and applications of spatial genomics and transcriptomics in determination of disease and treatment markers coupled with the growth in preference toward personalized medicines.

The spatial genomics & transcriptomics market is anticipated to reach USD XXX.X million by 2030 from USD XXX.X million in 2021, at a CAGR of 8.9% during the forecast period.

Increasing adoption of spatial genomics and transcriptomics technologies in various applications such as stem cell and cancer research, tissue-specific gene expression studies, embryogenesis and in-vitro fertilization, and characterization of non-coding RNAs among others, is expected to drive the growth of the spatial genomics and transcriptomics market during the forecast period 2022-2030.

Growth Drivers:

The growing application of spatial genomics & transcriptomics in academic & research institute is one of the major factor driving the growth of the market. Genomics & trancriptomics techniques are widely used for the extensive evaluation of a wide range of diseases. Spatial genomic and transcriptomics technology has broader applications in the sector, such as the human cell atlas, further boosting the market growth during the forecast period.

Spatial genomics and transcriptomics technologies have been comprehensively used for drug discovery and development over the past few years. Spatial transcriptomics is a revolutionary technique that allows study of cell composition, physiology, and disease development in extensive detail. Spatial transcriptomics along with spatial genomics play a crucial role in accelerating drug discovery and development processes.

Increased R&D spending by key companies to develop new data regarding genetic consequences to counter the global rise in different infectious diseases coupled with public-private collaboration is driving the growth of spatial genomics & trancriptomics market during the forecast period.

The increasing cases of cancer all around the globe increases the rate of diagnosis and opens the scope of advanced diagnostics. Due to its advantages in genetic mapping, understanding of locations of infection genes and understanding of drug adaption according to the genetic module of disease the potential of spatial genomics & transcriptomics as cancer diagnosis technique is growing rapidly.

 

Spatial Genomics & Transcriptomics Segmentation:

By Technology:

·         Spatial Transcriptomics

o   Sequencing-based Methods

§  Laser Capture Microdissection (LCM)

·         FFPE Tissue Samples

·         Others

§  Transcriptome In-vivo Analysis (TIVA)

§  In Situ Sequencing

§  Microtomy Sequencing

o   IHC

o   Microscopy-based RNA Imaging Techniques

§  Single Molecule RNA Fluorescence In-situ Hybridization (smFISH)

§  Padlock Probes/ Rolling Circle Amplification

§  Branched DNA Probes

·         Spatial Genomics

o   FISH

o   Microscopy-based Live DNA Imaging

o   Genome Perturbation Tools

o   Massively-parallel Sequencing

o   Biochemical Techniques

o   Others

By Product:

·         Instruments

o   By Mode

§  Automated

§  Semi-automated

§  Manual

o   By Type

§  Sequencing Platforms

§  IHC

§  Microscopy

§  Flow Cytometry

§  Mass Spectrometry

§  Others

·         Consumables

·         Software

o   Bioinformatics Tools

o   Imaging Tools

o   Storage and Management Databases

By Application:

·         Translational Research

·         Drug Discovery & Development

By End-User:

·         Pharmaceutical & Biotechnology Companies

·         Contract Research Organizations

·         Academic & Research Institutes

By Region:

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East and Africa

 

Spatial Genomics & Transcriptomics Market by Technology Review:

Based on the technology, the spatial genomics & transcriptomics market is segmented into two segments: spatial transcriptomics, and spatial genomics. On the basis of technology, spatial transcriptomics segment is expected to dominate the market in terms of market share, while it is forecasted to grow at the highest rate in terms of CAGR during the forecast period. The major reason driving the growth of the segment is higher adoption of spatial transcriptomics as compared to spatial genomics for the transcriptomic study of single cell.

 

Spatial Genomics & Transcriptomics Market by Product Review:

Based on the product, the spatial genomics & transcriptomics market is segmented into: instruments, consumables, and software. On the basis of product, the consumables segment is expected to be the largest in terms of market share, while it is projected to grow at the fastest rate in terms of CAGR during the forecast period. frequent purchase of consumables, higher product penetration, and wide product availability is boosting the revenue growth of the segment in the spatial genomics & transcriptomics market during the forecast period of 2022-2030

Spatial Genomics & Transcriptomics Market by Application Review:

Based on the application, the spatial genomics & transcriptomics market is segmented into: translational research, and drug discovery & development. On the basis of application, the translational research segment is expected to be the largest in terms of market share, while the segment is projected to grow at the fastest rate in terms of CAGR during the forecast period. The application of spatial omics technologies in translational research may potentially improve research by providing a thorough analysis of physiology and status of a disease, which further propels the development of novel diagnostic equipment and therapies.

Spatial Genomics & Transcriptomics Market by End-User Review:

Based on the end-user, the spatial genomics & transcriptomics market is segmented into: into pharmaceutical & biotechnology companies, contract research organizations, and academic &research institutes. On the basis of end-user, academic & research institute segment is expected to be the largest in terms of market share, while the segment is projected to grow at the fastest rate in terms of CAGR during the forecast period. Spatial genomic analyses are increasingly being used in academic research institutions as they provide a comprehensive analysis of various disorders.

Regional Outlook:

The spatial genomics & transcriptomics market research report offers detailed analysis and forecasts for five major regions i.e., North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa.

The North America region is forecasted to dominate the global spatial genomics & transcriptomics market followed by Asia Pacific, Europe and Latin America during the forecast period 2022-2030.

The North America spatial genomics & transcriptomics market is driven by the factors like increasing prevalence of chronic disease and technological advancements coupled with the launch of cell therapies to treat cancer. Increasing adoption of solutions for spatial profiling in cancer research and increasing investment by both government and private companies on genomics-based research and development is expected to boost the spatial genomics & transcriptomics market in North America during the forecast period 2022-2030.Within the North America, United States and Canada are seen to hold a dominant portion of the spatial genomics & transcriptomics market due to massive investments in cancer research to address the high demand for advanced diagnostic and treatment methods. According to the ACS, in 2021, there were an estimated 1.9 million new cancer cases diagnosed in the United States. Additionally, according to the Public Health Agency of Canada data published in October 2021, an estimated 2 in 5 Canadians were diagnosed with cancer in their lifetime, and in 2021, an estimated 229,000 Canadians were diagnosed with cancer. Strong base of healthcare facilities, widespread utilization of medications, rising number of research activities has fueled the growth of regional spatial genomics & transcriptomics market.

Asia Pacific is expected to witness the highest growth rate in terms of CAGR during the forecast period owing to the overwhelming population, growing demand for quality healthcare, rise in medical tourism, growing research activities in the region, and availability of massive untapped markets in the Asia Pacific region. Rise in medical tourism, increasing government initiatives to promote awareness, and growing research activities in the region is positively impacting the growth of spatial genomics & transcriptomics market in the region.

Key Companies in Spatial Genomics & Transcriptomics Market:

The research report offers a competitive analysis of prominent companies operating in the spatial genomics & transcriptomics market. Some of the leading players profiled in the market research report include:

·         10X Genomics, Inc

·         Bio-Techne Corporation (Advanced Cell Diagnostics, Inc)

·         Dovetail Genomics, LLC

·         Illumina, Inc

·         Nanostring Technologies, Inc

·         NateraInc

·         PerkinElmer Inc (Horizon Discovery Group Plc)

·         S2 Genomic

·         Seven Bridges Genomics

·         Akoya Biosciences, Inc

·         BioSpyder Technologies Inc

·         Fluidigm Corporation

·         Genomic Vision SA

·         Rarecyte, Inc

·         Rebus Biosystems, LLC

·         Resolve Biosciences

·         Singular Genomics System, Inc

·         Tecan Group Ltd (Nugen Technologies, Inc)

·         Ultivue, Inc

·         VeranomeBiosystems LLC

·         Vizgen Corporation

·         Lunaphore Technologies SA

·         Other Players